FDA clearance of the BCL System will give surgeons access to precise information about each breast tumor that has never before been available to them, according to the company.
The MedTech industry has seen significant growth and raised expectations as it adapts to evolving healthcare needs in the wake of the COVID-19 pandemic. The industry’s ability to make technology a part of everyday life will be key to driving growth and evolving with the demands of a disparate patient population.
North Carolina healthcare provider supplies clinicians with immediate, on-site access to 3D-printed anatomic models and support through Ricoh Managed Services.
Point of care 3D printing of medical devices has abundant potential. However, many regulatory uncertainties remain.
The new European Regulation related to medical devices – as adopted by the European Union (EU) Council on 5 April 2017 – does not provide 3D printing with a specific status, raising questions regarding the regulations applicable to this medical innovation.
Medtech manufacturers are taking advantage of this global opportunity.
The agency addresses design and manufacturing considerations, along with device submissions for product approval.
A peek at the latest miniaturization trends, including nano-robots that transport therapeutics to tumors.
Design freedom, increased accuracy, and customization, are fueling growth.
For 3D printing to thrive in the medical device space, the use of biomaterials must be expanded.